Innovative Eyewear posts 71% revenue growth in Q2
Innovative Eyewear (NASDAQ:LUCY) reported preliminary unaudited net sales of approximately $0.99 million for Q2 2026, representing a year-over-year increase of about 71%.
Innovative Eyewear (NASDAQ:LUCY) reported preliminary unaudited net sales of approximately $0.99 million for Q2 2026, representing a year-over-year increase of about 71%.
Ondas Holdings (NASDAQ:ONDS) said it has entered into an agreement to acquire DZYNE Technologies in a transaction valued at approximately $875.8 million in cash and stock.
Iridium (NASDAQ:IRDM) announced it completed the acquisition of Aireon to combine global satellite communications with space-based air traffic surveillance.
easyJet said it has agreed in principle to a £5.5 billion ($7.3 billion) cash offer from U.S. investment firm Castlelake after rejecting four earlier proposals.
Agenus (NASDAQ:AGEN) reported updated Phase 1b clinical data for its botensilimab (BOT) and balstilimab (BAL) combination in patients with refractory microsatellite-stable metastatic colorectal cancer without active liver metastases.
Solaris Energy Infrastructure (NYSE:SEI) announced it executed an agreement to acquire Global Energy Services Alliance to scale up its full-cycle power generation solutions.
Ceva (NASDAQ:CEVA) announced a landmark licensing agreement with a major U.S. software and AI platform company to support a custom AI silicon program aimed at next-generation intelligent computing devices.
Ionis Pharmaceuticals (NASDAQ:IONS) announced it completed patient enrollment in the pivotal pediatric cohort of its global Phase 3 REVEAL clinical study evaluating its investigational RNA-targeted medicine, obudanersen.
Pharvaris (NASDAQ:PHVS) announced the FDA accepted its regulatory application for its 20 mg hereditary angioedema on-demand treatment capsule.
Maximus (NYSE:MMS) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.33 per share to reward equity investors.
GET YOUR GRAFA EDGE NOW
We'll switch on a 30-day Edge trial as a welcome gift
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy